Moreover, these Akt/mTOR inhibitors enhanced cancer cell sensitivity to adriamycin, thereby leading to a significantly increased ratio of apoptotic cells expressing microRNA‐221 (P < .05, Figure 5D). The gene discussed is AKT1; the disease is cancer.